The company is aggressively tapping the ATM market after already selling $6.2M under the prior facility, indicating urgent cash needs. With a $7M market cap and the stock at $0.395, the $2.5M offering is highly dilutive. Traders should expect continued downward pressure from ATM sales and monitor for any news on clinical pipeline (SGX302 for cutaneous T-cell lymphoma, HyBryte) or partnership that could stem the dilution. The cross-filing amplifiers confirm this as a significant bearish event.
SNGX drugs
SNGX drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 29 $0.4000entry
- T+1 · 5mo ago −1.00%α −1.78% · $0.3960
- T+5 · 4mo ago −3.80%α −5.19% · $0.3848
- T+20 · 4mo ago −7.17%α −6.90% · $0.3713
- T+60 · 8w ago −3.75%α −8.14% · $0.3850
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Soligenix, Inc. filed a 424B5 prospectus supplement to increase the maximum dollar amount of common stock it can sell under its existing at-market issuance sales agreement with Rodman & Renshaw LLC from the prior $6,406,000 (of which ~$6,234,000 has been sold) to an additional $2,500,000. At a current stock price of $0.395 and a market cap of $7M, the new $2.5M offering represents dilution of approximately 35% of the company's pre-offering market value, executed through an ATM facility.
Key Facts
- New ATM offering of up to $2,500,000 of common stock
- Prior $6,406,000 ATM facility now fully utilized (approx. $6,234,000 already sold)
- Offering replaces all unsold amounts under prior prospectus supplement
- Stock price at filing: $0.395 per share (down 72% from $1.42 used in public float calculation)
- Company has already sold $7,700,914 in aggregate under General Instruction I.B.6 in the prior 12 months
- Current public float: $30,702,784 (based on 21,621,679 shares held by non-affiliates at $1.42 price)
- Market cap: $7M at date of filing, making $2.5M offering ~35% dilution of market value
- Rodman & Renshaw LLC acts as sales agent
- Company is a smaller reporting company
Financial Impact
$2,500,000 new common stock offering representing approximately 35% dilution of $7M market cap at the time of filing
Risk Factors
- Significant near-term dilution from ongoing ATM sales
- Stock price already at $0.395, down sharply from the $1.42 reference price used in the public float calculation
- Company has exhausted prior ATM facility and is immediately requesting new capacity, signaling persistent cash burn
- Potential Nasdaq minimum bid price non-compliance risk if stock continues to decline
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001104659-26-078241 |
| Document: 0001104659-26-078241-index-headers.html | 0001104659-26-078241 |
| Document: 0001104659-26-078241-index.html | 0001104659-26-078241 |
| Document: 0001104659-26-078241.txt | 0001104659-26-078241 |
Track record
7 reports on SNGX
4 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +69.30% at T+20 after the Apr 3, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 6, 202610d ago Press Release Neutral 4/10 Entry $0.3350 Now $0.2900 −13.43% settles Feb 4
- Nov 2, 202614d ago SC 13G/A Neutral 2/10 Entry $0.3612 Now $0.2900 −19.71% settles Jan 29
- Jun 26, 202620w ago 8-K Bearish 6/10 Entry $0.4000 to $0.3850 Now $0.2900 +27.50% ▲ +3.75% +8.14% vs SPY
- Jun 26, 202620w ago 424B5 Bearish 7/10 Viewing Entry $0.4000 to $0.3850 Now $0.2900 +27.50% ▲ +3.75% +8.14% vs SPY
- May 28, 202624w ago 8-K Bearish 5/10 Entry $0.9100 to $0.4047 Now $0.2900 +68.13% ▲ +55.53% +56.71% vs SPY
- May 28, 202624w ago 424B5 Bearish 6/10 Entry $0.9100 to $0.4047 Now $0.2900 +68.13% ▲ +55.53% +56.71% vs SPY
- Apr 3, 202632w ago EFFECT Bearish 6/10 Entry $1.14 to $0.3970 Now $0.2900 +74.56% ▲ +65.18% +78.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers